Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling

Nifuroxazide is an antidiarrheal medication that has promising anticancer activity against diverse types of tumors. The present study tested the anticancer activity of nifuroxazide against Ehrlich’s mammary carcinoma grown in vivo. Furthermore, we investigated the effect of nifuroxazide on IL-6/jak2...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Sherbiny, Mohamed, El-Sayed, Rehab M., Helal, Mohamed A., Ibrahiem, Afaf T., Elmahdi, Hoda S., Eladl, Mohamed Ahmed, Bilay, Shymaa E., Alshahrani, Asma M., Tawfik, Mona K., Hamed, Ziad E., Mohamed, Amany O., Zaitone, Sawsan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621155/
https://www.ncbi.nlm.nih.gov/pubmed/34833950
http://dx.doi.org/10.3390/molecules26226858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621155/
https://www.ncbi.nlm.nih.gov/pubmed/34833950
http://dx.doi.org/10.3390/molecules26226858

Ejemplares similares